Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Dr Agarwal's Health Care Ltd (AGARWALEYE)
Market Closed
10 Aug, 10:00
XNSE
All
(2)
IN
(2)
XNSE
Primary
MSE
₹
560.
70
+14.45
+2.6453%
₹
144.8B
Market Cap
-
P/E Ratio
-
Div Yield
202,004
Volume
-
Eps
₹
546.25
Previous Close
Watching
Watch
Add Transaction
Day Range
543.35
564.5
Year Range
401
568
Want to track
AGARWALEYE
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Earnings
Statistics
Historical Data
Dr Agarwal's Health Care Ltd (AGARWALEYE) Statistics
Valuation metrics
Market Cap
144.8B
Enterprise value
182.55B
Trailing P/E (ttm)
129.75
Forward P/E
80.05
PEG ratio
2.5
Price/Sales (ttm)
8.33
Price/Book (mrq)
8.57
Enterprise Value/Revenue
8.78
Enterprise Value/EBITDA
30.35
Overview
Shares outstanding
316.96M
Float
60.08M
Shares short
-
% Held by insiders
0.75%
% Held by institutions
0.18%
Average volume (10 days)
184.74K
Average volume (90 days)
96.24K
Price summary
52-Week low
401
52-Week high
568
Beta
-
50-Day moving average
486.29
200-Day moving average
457.66
Financials
Fiscal year
Fiscal year ends
31 Mar 2025
Most recent quarter (mrq)
31 Dec 2025
Profitability
Profit margin
0.06%
Operating margin
0.14%
Operational effectiveness
Return on assets
0.03%
Return on equity
0.07%
Income Statement
Revenue (ttm)
19.76B
Revenue per share (ttm)
65.48
Quarterly revenue growth (yoy)
0.23%
Gross profit (ttm)
8.42B
EBITDA
4.91B
Net income to common (ttm)
1.26B
Diluted EPS (ttm)
4.19
Quarterly earnings growth (yoy)
0.51%
Balance Sheet
Total cash (mrq)
3.97B
Total cash per share (mrq)
8.86
Total debt (mrq)
9.83B
Total Debt/Equity (mrq)
0.53
Current ratio (mrq)
1.24%
Book value per share (mrq)
66.72
Cash Flow
Cash flow statement
1.43B
Levered free cash flow (LFCF)
834.6M